Evidence map›Paper›PMID 42151388›Full record

ArticleScientific reports2026

Macular degeneration collection.

Masahiro Miura, Matt Trinh, Juan E Gallo, Xinhua Shu

Abstract readEditorial
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masahiro MiuraComputational Optics Group, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 3058577, Japan. mmiuratokyo@gmail.com.
Matt TrinhSchool of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
Juan E GalloInstitute for Translational Medicine Research (IIMT), School of Biomedical Sciences, Austral University-National Scientific and Technical Research Council (CONICET), Pilar, Buenos Aires, Argentina.
Xinhua ShuDepartment of Biological and Biomedical Sciences, Glasgow Caledonian University, Glasgow, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related macular degeneration (AMD) remains a leading cause of severe vision loss among the older adults in developed countries. Improving patient outcomes is dependent on elucidating the complex pathogenesis of the disease and refining clinical and therapeutic strategies. This Collection showcases a diverse range of papers exploring the frontiers of imaging-based prediction, treatment optimization, mechanistic biology, and the assessment of visual function. Together, these studies provide critical insights to inform the next generation of AMD management.

Indexed as

Macular DegenerationHumansAge-related macular degenerationOphthalmologyRetinaVisual function

Identifiers

PMID42151388
PMCPMC13183965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.